iShares Biotechnology ETF (IBB)
NASDAQ: IBB
· Real-Time Price · USD
143.12
2.77 (1.97%)
At close: Sep 05, 2025, 3:59 PM
143.12
0.00%
Pre-market: Sep 08, 2025, 08:02 AM EDT
1.97% (1D)
Bid | 143.09 |
Market Cap | 9.98B |
AUM | 5.71B |
NAV | 143.05 |
EPS (ttm) | 6.62 |
PE Ratio (ttm) | 21.62 |
Shares Out | 69.7M |
Inception Date | Feb 5, 2001 |
Ask | 143.33 |
Volume | 2.7M |
Open | 140.65 |
Previous Close | 140.35 |
Day's Range | 140.65 - 143.22 |
52-Week Range | 107.43 - 150.57 |
Holdings | 251 |
Expense Ratio | 0.44% |
About IBB
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Asset Class Equity
Ticker Symbol IBB
Inception Date Feb 5, 2001
Provider Blackrock
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 46.91% of assets
Name | Symbol | Weight |
---|---|---|
Gilead Sciences, Inc... | GILD | 7.17% |
Amgen Inc. | AMGN | 6.75% |
Regeneron Pharmaceut... | REGN | 6.26% |
Vertex Pharmaceutica... | VRTX | 6.15% |
Alnylam Pharmaceutic... | ALNY | 5.91% |
Iqvia Holdings Inc. | IQV | 3.38% |
Insmed Incorporated | INSM | 3.15% |
Argenx Se | ARGX | 3.03% |
Mettler-toledo Inter... | MTD | 2.83% |
Natera, Inc. | NTRA | 2.28% |
Dividends Dividend Yield 0.38%
Ex-Dividend | Amount | Payment Date |
---|---|---|
Mar 18, 2025 | $0.1212 | Mar 21, 2025 |
Dec 17, 2024 | $0.0624 | Dec 20, 2024 |
Sep 25, 2024 | $0.2005 | Sep 30, 2024 |
Mar 21, 2024 | $0.1260 | Mar 27, 2024 |
Dec 20, 2023 | $0.1240 | Dec 27, 2023 |

2 months ago · seekingalpha.com
5 Stocks I'm Buying As The 'Big Beautiful Bill' Pushes The Market To New HighsThe Big Beautiful Bill boosts defense, industrials, and manufacturing, but healthcare and some REITs face headwinds from Medicaid cuts and policy shifts. AI optimism and the new legislation are fuelin...